Business Context and Reporting Period
Company: Superior Surgical Mfg. Co., Inc. (Superior Group of Companies, Inc.)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 1997
Business Overview: The Company manufactures and sells uniforms, service apparel, and related accessories for medical, industrial, commercial, and public safety markets. Uniforms and service apparel account for 90-95% of total sales. The Company operates as a "stock house," maintaining substantial inventories to fulfill orders within 1-2 weeks. It employs approximately 1,700 people and operates facilities in Florida, Arkansas, Georgia, and other locations.
Key Financial Metrics (Year Ended Dec 31, 1997)
| Metric | 1997 Value | 1996 Value |
|---|---|---|
| Net Sales | $144,607,048 | $141,420,626 |
| Net Earnings | $9,170,009 | $8,694,096 |
| Earnings Per Share (Basic) | $1.15 | $1.07 |
| Gross Margin | 33.5% | 33.6% |
| Net Profit Margin | 6.3% | 6.2% |
| Working Capital | $63,764,610 | $60,242,628 |
| Long-Term Debt | $13,466,666 | $15,733,333 |
| Cash and Equivalents | $8,889,948 | $4,718,632 |
| Shareholders' Equity | $78,117,115 | $74,156,424 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased by approximately 2.3% ($3.2 million) compared to 1996, driven by the continuation of new uniform programs.
- Profitability: Net earnings rose 5.5% to $9.17 million. Earnings per share increased from $1.07 to $1.15.
- Cost Management: Cost of goods sold as a percentage of sales decreased slightly to 66.5% from 66.4% in 1996, attributed to continued manufacturing efficiencies.
- Debt Reduction: Long-term debt decreased by approximately $2.27 million due to scheduled reductions. Interest expense as a percentage of sales dropped to 0.8% from 0.9%.
- Liquidity: Cash and cash equivalents increased by approximately $4.2 million, resulting in a year-end balance of $8.89 million.
- Share Repurchases: The Company repurchased and retired 151,900 shares of common stock in 1997, impacting cash flows by approximately $1.97 million.
Guidance, Outlook, and Risks
- Capital Expenditures: Capital expenditures for 1998 are expected to be approximately $13 million, a significant increase from $2.24 million in 1997. This is primarily due to the acquisition and implementation of new computer hardware and software.
- Dividends: The Company paid $0.455 per share in dividends in 1997. Management expects to continue paying dividends, with amounts potentially increasing as earnings and business conditions warrant. Approximately $16.32 million in retained earnings were available for dividends as of year-end.
- Acquisition: Effective January 2, 1998, the Company acquired the net assets of J & L Group, Inc., a manufacturer of embroidered sportswear with 1997 revenues of approximately $6.7 million.
- Year 2000 Issue: Management is reviewing the Year 2000 issue and believes essential software and technologies will not be materially affected.
- Legal/Contingencies: A $6.5 million payment to settle a dispute with the federal government (related to VA contracts) was made in 1996. No additional charges were incurred in 1997, and the Company is free to continue selling to federal agencies.
- Debt Covenants: The Company is in full compliance with all debt covenants, including tangible net worth ($55 million) and working capital ratio (2.5:1) requirements.
Investor Verification Checklist
- Capital Expenditure Plan: Verify the necessity and expected ROI of the projected $13 million capital expenditure for 1998, particularly regarding IT infrastructure.
- Acquisition Integration: Monitor the financial impact and integration progress of the J & L Group, Inc. acquisition in the 1998 reporting period.
- Inventory Levels: Review inventory turnover ratios given the Company's "stock house" model and the $42.5 million inventory balance.
- Debt Servicing: Confirm continued compliance with debt covenants, specifically the tangible net worth and working capital ratios, amidst increased capital spending.
- Customer Concentration: Note that the largest customer accounted for no more than 4% of 1997 sales, indicating low concentration risk.